About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in New York | 76 Studies

Clinical Trials Alzheimer's DiseaseNew York

Alzheimer's Disease Clinical Trials in New York

Find 76 clinical trials for alzheimer's disease near New York, New York. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in New York

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 61-76 of 76 trials

TerminatedA Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's DiseaseThe purpose of this study was to test whether two investigational drugs called CAD106 and CNP520, administered separately, could slow down the onset and progression of clinical…NCT02565511·Phoenix, Arizona and 128 others

Alzheimer's Disease Trials in Other Cities

Los Angeles Chicago Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedAlzheimer's Disease Prevention TrialThis is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.NCT00000176·Birmingham, Alabama and 21 others

CompletedTelehealth Education Program for Caregivers of Veterans With DementiaThis study was designed to evaluate the impact of a Telehealth Education Program (TEP) on outpatient veterans with moderate to severe dementia and their spouse caregivers.NCT00105638·Albany, New York and 1 other

CompletedCholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease StudyCLASP is a research study to investigate the safety and effectiveness of simvastatin (a cholesterol lowering drug or statin) to slow the progression of Alzheimer's disease (AD).NCT00053599·Birmingham, Alabama and 43 others

CompletedEfficacy and Safety of AG10 in Subjects With Transthyretin Amyloid CardiomyopathyPhase 3 efficacy and safety study to evaluate acoramidis (AG10) HCl 800 mg administered orally twice a day compared to placebo in subjects with symptomatic Transthyretin Amyloid…NCT03860935·Los Angeles, California and 103 others

CompletedTreatment of Psychosis and Agitation in Alzheimer's DiseaseClinically, many patients with AD show no response or minimal response to antipsychotics for symptoms of agitation/aggression or psychosis, or they have intolerable side effects…NCT02129348·Miami, Florida and 3 others

CompletedResveratrol for Alzheimer's DiseaseResveratrol is derived from plants and is found in highest levels in red wine and the skin of red grapes.NCT01504854·Phoenix, Arizona and 25 others

CompletedMemory Improvement Through Nicotine Dosing (MIND) StudyThe purpose of the study is to see if daily transdermal nicotine is able to produce a significant cognitive, clinical and functional improvement in participants with MCI.NCT02720445·Scottsdale, Arizona and 35 others

CompletedAlzheimer's Disease Neuroimaging Initiative Grand OpportunityThe purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1), to examine how brain imaging technology…NCT01078636·Birmingham, Alabama and 54 others

CompletedA Study of RO4602522 in Participants With Moderate Severity Alzheimer Disease on Background Alzheimer Disease TherapyThis Phase II, multicenter, randomized, double-blind, parallel-group, placebo-controlled study will evaluate the efficacy and safety of RO4602522 in participants with moderate…NCT01677754·Anaheim, California and 141 others

CompletedAlzheimer's Disease Neuroimaging Initiative 2The purpose of this study is to build upon the information obtained in the original Alzheimer's Disease Neuroimaging Initiative (ADNI1) and ADNI-GO (Grand Opportunity; a study…NCT01231971·Birmingham, Alabama and 57 others

TerminatedA Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205The primary objective is to evaluate the safety and tolerability of aducanumab over 100 weeks of treatment after a wash-out period imposed by discontinuation of feeder studies in…NCT04241068·Birmingham, Alabama and 296 others

RecruitingScreening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease StudiesThis study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.NCT07177352·Birmingham, Alabama and 228 others

CompletedAgitation in Alzheimer's DiseaseAgitation affects 70 to 90 percent of patients with AD. Signs of agitation include verbal and physical aggressiveness, irritability, wandering, and restlessness.NCT00000179·Los Angeles, California and 15 others

RecruitingNYSCF Scientific Discovery BiobankThe New York Stem Cell Foundation (NYSCF) Research Institute is performing this research to accelerate diverse disease research using cells from the body (such as skin or blood…NCT06203106·New York, New York

RecruitingAcoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR VariantTransthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque-like substance that…NCT06563895·La Jolla, California and 103 others

PreviousPage 4 of 4

Other Conditions in New York

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia